Effect of anti-CD4 monoclonal antibody and cyclosporine a or a combination of both on chronic rejection in the rat aortic allograft model
Lácha, J.; Lehmann, M.; Chadimová, M.; Brock, J.; Havlícková, J.
Transplantation Proceedings 26(6): 3242-3243
1994
ISSN/ISBN: 0041-1345 PMID: 7998129 Document Number: 435576
Document emailed within 1 workday
Related Documents
Wang, X.H.; Xie, T. 1993: Anti-CD3 and -CD4 monoclonal antibody in the treatment of steroid-resistant renal allograft rejection Chinese Medical Journal 106(11): 821-824Zhang, Z.; Zhong, R.; Grant, D.; Garcia, B.; White, M.; Stiller, C.; Lazarovits, A. 1995: Prevention and reversal of renal allograft rejection by monoclonal antibody to CD45RB in the mouse model Transplantation Proceedings 27(1): 389
McLigeyo, S.O.; Notghi, A.; Anderton, J.L.; Dick, J. 1990: Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody East African Medical Journal 67(9): 667-673
Hayes, J.M.; Spencer, W.; Valenzuela, R.; Caulfield, M.; Novick, A.C. 1989: Immunosuppression with an anti-IL-2 receptor monoclonal antibody in a baboon renal allograft model Transplantation Proceedings 21(1 Part 1): 1006-1009
Troncoso, P.; Stepkowski, S.M.; Wang, M.E.; Qu, X.; Chueh, S.C.; Clark, J.; Kahan, B.D. 1999: Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine Transplantation 67(1): 145-151
d'Apice, A.J.; Thurlow, P.J.; Ihle, B.U.; Lovering, E.K.; McKenzie, I.F. 1987: Treatment of acute renal allograft rejection with a monoclonal antibody to a T cell antigen (HuLy-m2) Australian and New Zealand Journal of Medicine 17(2): 210-215
Paul, L.C.; Chea, R.; Davidoff, A.; Benediktsson, H. 1994: Efficacy of long-term cyclosporine treatment to prevent chronic renal allograft rejection in the rat Transplantation Proceedings 26(5): 2567-2568
Noël, C.; Hazzan, M.; Coppin, M.C.; Pruvot, F.R.; Bridoux, F.; Lelièvre, G. 1995: Renal transplant artery thrombosis following treatment of allograft rejection with monoclonal anti-CD3 antibodies (OKT3) Transplantation Proceedings 27(4): 2438-2439
Wang, M.; Qu, X.; Stepkowski, S.M.; Chou, T.C.; Kahan, B.D. 1996: Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus Transplantation 61(3): 458-464
Widmer, U.; Frei, D.; Keusch, G.; Burger, H.R.; Largiader, F.; Binswanger, U. 1988: OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine a Transplantation Proceedings 20(5 Suppl 6: 90-95
Tsuji, K.; Nose, Y.; Kusama, M. 1983: Regulation of graft rejection using anti-lymphocyte monoclonal antibody Nihon Rinsho. Japanese Journal of Clinical Medicine 41(4): 834-840
Haga, M.; Tsuchida, M.; Hirahara, H.; Watanabe, T.; Hayashi, J.I.; Watanabe, H.; Matsumoto, Y.; Abo, T.; Eguchi, S. 2000: Synergistic effect of anti-T cell receptor monoclonal antibody and 15-deoxyspergualin on cardiac xenograft survival in a mouse-to-rat model Transplantation 69(12): 2613-2621
Thomas, J.; Thomas, F.; Lee, H.M. 1977: Studies of lymphocyte-dependent antibody in human chronic renal allograft rejection Transplantation Proceedings 9(1): 65-68
Kupiec-Weglinski, J.W.; Hahn, H.J.; Kirkman, R.L.; Volk, H.D.; Mouzaki, A.; DiStefano, R.; Tellides, G.; Dallman, M.; Morris, P.J.; Strom, T.B. 1988: Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy Transplantation Proceedings 20(2 Suppl 2): 207-216
Cacalano, N.A.; Cleveland, W.L.; Erlanger, B.F. 1991: Characterization of a monoclonal anti-idiotypic antibody that mimics cyclosporine a in a single binding system Journal of Immunology 147(9): 3012-3017
Hengster, P.; Pescovitz, M.D.; Hyatt, D.; Margreiter, R. 1999: Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection. Roche Study Group Transplantation 68(2): 310-313
Schwaiger, E.; Regele, H.; Wahrmann, M.; Werzowa, J.; Haidbauer, B.; Schmidt, A.; Böhmig, G.A. 2010: Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report Clinical Transplants 2010: 391-396
Evans, D.M.; Fabre, J.W.; Millard, P.R.; Morris, P.J. 1979: Effect of splenectomy alone and in combination with antilymphocyte serum on renal allograft rejection in the rat Transplantation 27(6): 389-391
Otto, G.; Hofmann, W.J.; Gaweco, A.S.; Seelos, R.; Herfarth, C.; Meuer, S. 1996: Influence of the anti-CD25 monoclonal antibody BT563 on clinical and biological rejection after orthotopic liver transplantation Transplantation Proceedings 28(6): 3210-3211
Vossen, A.C.; Tibbe, G.J.; van Oudenaren, A.; Vredendaal, A.E.; Benner, R.; Savelkoul, H.F. 1994: A rat anti-mouse CD3 monoclonal antibody induces long-term skin allograft survival without inducing side effects Transplantation Proceedings 26(6): 3157-3158